Late post: AMAZING City of Hope GU mini-retreat planned by Abhishek Tripathi. He invited the stellar Irbaz Riaz MD,MS,MBI,PhD Mayo Clinic Comprehensive Cancer Center who enlightened us re: applications of #AI in #oncology . Had a chance to show him around our beautiful campus w Hedyeh Ebrahimi & Regina Barragan-Carrillo! Tanya Dorff…

In this analysis of PRO data from the landmark LIBRETTO-001 trial published by Alexander Drilon MD Vivek Subbiah, MD Benjamin Besse Ben Solomon @keunchilpark Herbert Loong and others, the majority of patients with RET cancers that we treated remained stable or improved demonstrating the…

Sharing our editorial on Rationalizing rules for immunotherapy combination trials - Vivek Subbiah, MD
Aakash Desai, MD, MPH Sarah Cannon Docs ACS Journal Cancer American Cancer Society
oncodaily.com/blog/63699.html

#ASCO #Cancer #PrecisionMedicine #ClinicalTrials #OncoDaily #Oncology

Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy ⁦ACS Journal Cancer⁩ acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Interpreting and integrating genomic tests results in clinical cancer care - Vivek Subbiah, MD
CA: A Cancer Journal for Clinicians American Cancer Society Raffaella Casolino Ben Westphalen Clare Turnbull- Prof/NHS Dr Chantal Pauli Debyani Chakravarty, PhD 🇺🇦
oncodaily.com/64475.html

#ACS #Cancer #OncoDaily #Oncology

So honored to deliver the opening keynote at Stat4Onc Annual meeting! - Vivek Subbiah, MD
UConn U.S. FDA MD Anderson Cancer Center
oncodaily.com/64385.html

#OncoDaily #Oncology #Cancer #Stat4Onc #HealthCare

Ready, set, and go—the mission toward unlocking the full potential of KRAS-targeted 🎯💊 therapies in CRC has just begun.

🚨Pleased to share our editorial 👉Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer | JCO Oncology Practice JCO Oncology Practice ASCO ASCOPost Journal of Clinical Oncology
ascopubs.org/doi/pdf/10.120…

🚨🥁 Hot off the press! 📰 Delighted to share our editorial in ASCO JCO Oncology Practice
🚀'Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer.'
⚡️Let's accelerate progress in KRAS targeting together #KRAS #CRCSM KRASKickers Fight Colorectal Cancer OncoDaily OncoAlert…

Undiagnosed US Cancer Cases During the COVID-19 Pandemic JAMA JAMA Oncology jamanetwork.com/journals/jamao…

Advancing Truth in Oncology by Complementing Clinical Trials With Evidence From Clinical Practice Elad Sharon JAMA Oncology
jamanetwork.com/journals/jamao…

Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma
A Nonrandomized Clinical Trial
Second-/third-line nivolumab plus high-dose ipilimumab may benefit patients with metastatic urothelial carcinoma JAMA JAMA Oncology
jamanetwork.com/journals/jamao…

⭐️Picking that needle in haystack --> ROS1 fusion in Glioblastoma.
👉Striking response to entrectinib in glioblastoma harboring ROS1 fusion - nice work by Lombardi Giuseppe Marta Padovan IOV - Istituto Oncologico Veneto et al 🎯🧬🇮🇹EANO SNO #glioblastoma #precisionmedicine OncoDaily…

Rationalizing rules for immunotherapy combination trials: About time for precision immunotherapy

Vivek Subbiah, MD OncoAlert OncoDaily #Oncology #Meded #medx

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Facilitating a midnight session (!) on #cancer pain for 80 of Indonesia's expert oncologists and #palliativecare clinicians who've been setting aside their Saturdays to rapidly learn best practices in cancer #supportivecare ! High-quality holistic symptom management impacts second…

🌞Statisticians: Are you a frequentist or Bayesian?

Me: I'm methodology agnostic - in addition to being tumor agnostic, age agnostic, biomarker agnostic drug developer. I'm okay with any method that can give the right answer in the quickest time with the fewest patient…

⭐️My first time at the UConn campus! So honored to deliver the opening keynote at #Stat4Onc Annual meeting!
👉🏼“Transforming Healthcare with Basket Trials & Patient-Centric Tissue-agnostic Precision Medicine: A Visionary Approach”
✅Grateful for the warm reception from all the…

Authors proposed a precision-driven approach for patient selection to identify successful combinations of immunotherapy to improve outcomes for patients with cancer. Vivek Subbiah, MD #Cancer #PrecisionMedicine #immunotherapy OncoAlert OncoDaily #ASCO24

Authors proposed a precision-driven approach for patient selection to identify successful combinations of immunotherapy to improve outcomes for patients with cancer
Vivek Subbiah, MD Aakash Desai, MD, MPH #Cancer #immunotherapy OncoAlert OncoDaily #ASCO24

doi.org/10.1002/cncr.3…